Vanguard Group’s Sensus Healthcare SRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.9M | Hold |
728,916
| – | – | ﹤0.01% | 3441 |
|
|
2025
Q3 | $2.29M | Sell |
728,916
-11,106
| -2% | -$43.6K | ﹤0.01% | 3536 |
|
|
2025
Q2 | $3.51M | Hold |
740,022
| – | – | ﹤0.01% | 3325 |
|
|
2025
Q1 | $3.5M | Hold |
740,022
| – | – | ﹤0.01% | 3301 |
|
|
2024
Q4 | $5.12M | Sell |
740,022
-39,030
| -5% | -$286K | ﹤0.01% | 3263 |
|
|
2024
Q3 | $4.52M | Hold |
779,052
| – | – | ﹤0.01% | 3303 |
|
|
2024
Q2 | $4.15M | Hold |
779,052
| – | – | ﹤0.01% | 3331 |
|
|
2024
Q1 | $2.96M | Hold |
779,052
| – | – | ﹤0.01% | 3471 |
|
|
2023
Q4 | $1.84M | Hold |
779,052
| – | – | ﹤0.01% | 3629 |
|
|
2023
Q3 | $2.16M | Hold |
779,052
| – | – | ﹤0.01% | 3557 |
|
|
2023
Q2 | $2.45M | Sell |
779,052
-8,033
| -1% | -$29K | ﹤0.01% | 3590 |
|
|
2023
Q1 | $4.1M | Buy |
787,085
+59,849
| +8% | +$430K | ﹤0.01% | 3396 |
|
|
2022
Q4 | $5.4M | Buy |
727,236
+133,365
| +22% | +$1.2M | ﹤0.01% | 3267 |
|
|
2022
Q3 | $7.44M | Hold |
593,871
| – | – | ﹤0.01% | 3099 |
|
|
2022
Q2 | $4.56M | Sell |
593,871
-2,353
| -0.4% | -$19.8K | ﹤0.01% | 3425 |
|
|
2022
Q1 | $6.03M | Buy |
596,224
+116,409
| +24% | +$1.06M | ﹤0.01% | 3436 |
|
|
2021
Q4 | $3.46M | Sell |
479,815
-708
| -0.1% | -$3.88K | ﹤0.01% | 3804 |
|
|
2021
Q3 | $1.73M | Hold |
480,523
| – | – | ﹤0.01% | 4104 |
|
|
2021
Q2 | $1.85M | Hold |
480,523
| – | – | ﹤0.01% | 3984 |
|
|
2021
Q1 | $1.84M | Buy |
480,523
+29,005
| +6% | +$119K | ﹤0.01% | 3878 |
|
|
2020
Q4 | $1.74M | Sell |
451,518
-79
| -0% | -$241 | ﹤0.01% | 3701 |
|
|
2020
Q3 | $1.14M | Hold |
451,597
| – | – | ﹤0.01% | 3629 |
|
|
2020
Q2 | $1.38M | Hold |
451,597
| – | – | ﹤0.01% | 3535 |
|
|
2020
Q1 | $1.13M | Hold |
451,597
| – | – | ﹤0.01% | 3458 |
|
|
2019
Q4 | $1.6M | Buy |
451,597
+400
| +0.1% | +$1.81K | ﹤0.01% | 3509 |
|
|
2019
Q3 | $2.71M | Buy |
451,197
+1,579
| +0.4% | +$9.18K | ﹤0.01% | 3347 |
|
|
2019
Q2 | $2.49M | Hold |
449,618
| – | – | ﹤0.01% | 3409 |
|
|
2019
Q1 | $3.16M | Buy |
449,618
+5,220
| +1% | +$40.3K | ﹤0.01% | 3308 |
|
|
2018
Q4 | $3.29M | Buy |
444,398
+138,565
| +45% | +$880K | ﹤0.01% | 3223 |
|
|
2018
Q3 | $2.56M | Buy |
305,833
+99,444
| +48% | +$720K | ﹤0.01% | 3448 |
|
|
2018
Q2 | $1.5M | Buy |
206,389
+126,062
| +157% | +$823K | ﹤0.01% | 3575 |
|
|
2018
Q1 | $469K | Buy |
80,327
+4,219
| +6% | +$23.8K | ﹤0.01% | 3796 |
|
|
2017
Q4 | $397K | Buy |
76,108
+19,350
| +34% | +$105K | ﹤0.01% | 3799 |
|
|
2017
Q3 | $283K | Buy |
+56,758
| New | +$279K | ﹤0.01% | 3857 |
|
Other funds holding SRTS
PRCP
DSCM
MIM
S
GWM
PCM
Vanguard Group's SRTS Position: Q4 2025 in Review
Vanguard Group held its Sensus Healthcare (SRTS) position steady in Q4 2025 at 728,916 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3441.
Vanguard Group first reported a position in SRTS in Q3 2017 and has held it in 34 quarters since. The position peaked at $7.44M in Q3 2022. 45 funds tracked by Wall St. Rank hold SRTS as of Q4 2025.
- Vanguard Group held 728,916 shares of Sensus Healthcare worth $2.9M as of Q4 2025.
- Vanguard Group left its Sensus Healthcare share count unchanged in Q4 2025.
- Sensus Healthcare made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3441 holding.
- Vanguard Group first reported a position in Sensus Healthcare in Q3 2017 and has held it in 34 quarters since.
- Vanguard Group's Sensus Healthcare position peaked at $7.44M in Q3 2022.
- 45 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.